Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (9)
P 2 (1)
P 3 (1)
P 4 (2)

Trial Status

Recruiting9
Not Yet Recruiting7
Active Not Recruiting2
Completed2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT07492862Not ApplicableNot Yet Recruiting

Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder

NCT07473375Recruiting

Indicators Affecting PVT Recanalization

NCT07459972Phase 4Completed

Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis

NCT07450651Not Yet Recruiting

Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

NCT07390344Not Yet Recruiting

VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

NCT07058155Phase 4Recruiting

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

NCT07291141Recruiting

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

NCT06669806Not ApplicableRecruitingPrimary

Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension

NCT07281846Not ApplicableRecruiting

TIPS With or Without BCAA

NCT07280390Not Yet Recruiting

Microplastics, Cirrhosis and Portal Hypertension

NCT07249294Not ApplicableActive Not Recruiting

Program to Avoid NSAIDs in Patients With Advanced Chronic Liver Disease

NCT07122622RecruitingPrimary

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

NCT06861075Not ApplicableRecruiting

CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound

NCT07062289Not ApplicableNot Yet Recruiting

Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient

NCT06687265Phase 2Recruiting

Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension

NCT06837974Not ApplicableNot Yet RecruitingPrimary

AI-guided TIPS Procedure

NCT06832826Active Not Recruiting

Colonic Polypectomy in Cirrhotic Patients With Portal Hypertension

NCT06589531Not ApplicableNot Yet RecruitingPrimary

Small Diameter TIPS in Patients with Severe Liver Atrophy and Variceal Bleeding

NCT06593015Completed

Protocol for Muscle Attenuation Cut-offs in Cirrhosis

NCT06513195Not ApplicableRecruitingPrimary

EUS-guided Response Assessment to NSBB

Scroll to load more

Research Network

Activity Timeline